Rimaljot Singh
Chandigarh, CH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting Alpha-Synuclein Aggregation With Chemical Chaperone IP-045: An Approach to Parkinson's Disease Therapy.
Journal: Drug development research
Published: November 01, 2025
5-Phenyl valeric acid attenuates α-synuclein aggregation and endoplasmic reticulum stress in rotenone-induced Parkinson's disease rats: A molecular mechanistic study.
Journal: Biochemical pharmacology
Published: January 19, 2024
Linalool acts as a chemical chaperone by inhibiting amyloid-β aggregation.
Journal: Neurochemistry international
Published: October 31, 2023
Endoplasmic reticulum stress and its role in various neurodegenerative diseases.
Journal: Brain research
Published: August 18, 2023
Identification of Bile Acid-Derived Chemical Chaperone(s) Targeting E46K-Mutated Alpha-Synuclein Protein to Treat Parkinson's Disease: Molecular Modelling, Docking, ADME, and Simulation Studies.
Journal: Applied biochemistry and biotechnology
Published: July 01, 2023
Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease.
Journal: The International journal of neuroscience
Published: August 17, 2021
Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
Published: May 14, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026